NeuBase Therapeutics, Inc. Annual Return On Assets in % from 2012 to 2022

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
NeuBase Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2012 to 2022.
  • NeuBase Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2023 was -62.4 %, a 17.5% increase year-over-year.
  • NeuBase Therapeutics, Inc. annual Return On Assets for 2022 was -75.7 %, a 42.7% decline from 2021.
  • NeuBase Therapeutics, Inc. annual Return On Assets for 2021 was -53 %, a 31.2% increase from 2020.
  • NeuBase Therapeutics, Inc. annual Return On Assets for 2020 was -77.1 %, a 83.9% increase from 2019.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 -75.7 -22.7 -42.7% Oct 1, 2021 Sep 30, 2022
2021 -53 +24.1 +31.2% Oct 1, 2020 Sep 30, 2021
2020 -77.1 +401 +83.9% Oct 1, 2019 Sep 30, 2020
2019 -478 -392 -452% Oct 1, 2018 Sep 30, 2019
2018 -86.6 -5.22 -6.42% Oct 1, 2017 Sep 30, 2018
2017 -81.4 -11.3 -16.1% Oct 1, 2016 Sep 30, 2017
2016 -70.1 -35.7 -104% Oct 1, 2015 Sep 30, 2016
2015 -34.4 +13.4 +28% Oct 1, 2014 Sep 30, 2015
2014 -47.8 +76.9 +61.7% Oct 1, 2013 Sep 30, 2014
2013 -125 -67.2 -117% Oct 1, 2012 Sep 30, 2013
2012 -57.5 Oct 1, 2011 Sep 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.